An evaluation of the efficacy and safety of erdafitinib for the treatment of bladder cancer |
| |
| Authors: | Jones T. Nauseef Dario M. Villamar Justin Lebenthal Panagiotis J. Vlachostergios |
| |
| Affiliation: | 1. Department of Medicine, Division of Hematology &2. Oncology, Weill Cornell Medicine , New York, NY, USA;3. Department of Medicine, Division of Internal Medicine, New York Presbyterian Hospital - Weill Cornell Medicine , New York, NY, USA |
| |
| Abstract: | ABSTRACT Introduction Treatment of unresectable or metastatic urothelial carcinoma (UC) has historically relied upon platinum-based chemotherapy and, more recently, immune checkpoint inhibitors. When tumors progress despite those therapies, remaining effective options are limited. |
| |
| Keywords: | Urothelial carcinoma bladder cancer fibroblast growth factor receptor targeted therapy |
|
|
